Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

IHC and endpoint RT-PCR for molecular subtyping of breast cancer (n = 41)
Molecular subtypes Based on IHC Based on endpoint RT-PCR
Using the expression of
ER, PR and HER2
Using St. Galen 2013 classification (ER, PR, HER2 & Ki-67) Using the expression of ER, PR and HER2
Frequency Frequency Frequency
Luminal-A 31 (75.6) 14 (34.1) 21 (51.2)
Luminal-B 7 (17.1) 24 (58.5) 8 (19.5)
TNBC 2 (4.9) 2 (4.9) 11 (26.8)
HER2+ 1 (2.4) 1 (2.4) 1 (2.4)

Values are presented as number (%). IHC, immunohistochemistry; RT-PCR, reverse transcription PCR; ER, estrogen receptor; PR, progesterone receptor; TNBC, triple negative breast cancer; HER2, human epidermal growth factor receptor 2; +, positive. The sum of the percentages does not equal 100% because of rounding.

J Cancer Prev 2023;28:64~74 https://doi.org/10.15430/JCP.2023.28.2.64
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd